Co-delivery of PARP and PI3K inhibitors by nanoscale metal-organic frameworks for enhanced tumor chemoradiation
12
This work was supported by the National Institutes of Health NIGMS as a Maximizing Investigators' Research Award,IR35GM119839-01 and Oregon State University College of Pharmacy Start-up Funds.We thank the Histology Core and the Advanced Light Microscopy Core at Oregon Health and Science University f
2020-05-12(万方平台首次上网日期,不代表论文的发表时间)
共15页
3003-3017